Homogeneous Opioid Trial Populations Could Simplify, Improve Data – Cmte

Limiting opioid trial populations to specific pain syndromes could improve safety and efficacy evaluations of the analgesics, FDA's Anesthetic & Life Support Drugs Advisory Committee suggested